MLICM
EVH icon

Metropolitan Life Insurance Company (MetLife)’s Evolent Health EVH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,022
Closed -$197K – 712
2024
Q1 		$197K Sell
6,022
-324
-5% -$10.3K 0.01% 723
2023
Q4 		$210K Hold
6,346
– – 0.01% 709
2023
Q3 		$173K Buy
6,346
+329
+5% +$9.14K 0.01% 750
2023
Q2 		$182K Buy
6,017
+1,584
+36% +$51.2K 0.01% 716
2023
Q1 		$144K Sell
4,433
-634
-13% -$20K 0.01% 810
2022
Q4 		$142K Buy
5,067
+179
+4% +$5.13K 0.01% 871
2022
Q3 		$176K Hold
4,888
– – 0.01% 721
2022
Q2 		$150K Sell
4,888
-362
-7% -$10.5K 0.01% 846
2022
Q1 		$170K Sell
5,250
-15,143
-74% -$396K 0.01% 900
2021
Q4 		$564K Sell
20,393
-1,991
-9% -$57.1K 0.01% 1342
2021
Q3 		$694K Hold
22,384
– – 0.01% 1220
2021
Q2 		$473K Buy
22,384
+1,149
+5% +$23K 0.01% 1560
2021
Q1 		$429K Sell
21,235
-933
-4% -$17.7K 0.01% 1512
2020
Q4 		$355K Hold
22,168
– – 0.01% 1583
2020
Q3 		$275K Hold
22,168
– – ﹤0.01% 1592
2020
Q2 		$158K Hold
22,168
– – ﹤0.01% 1968
2020
Q1 		$120K Sell
22,168
-22
-0.1% -$197 ﹤0.01% 1914
2019
Q4 		$201K Sell
22,190
-190
-0.8% -$1.54K ﹤0.01% 1924
2019
Q3 		$161K Hold
22,380
– – ﹤0.01% 2025
2019
Q2 		$178K Buy
22,380
+1,521
+7% +$18K ﹤0.01% 1963
2019
Q1 		$262K Sell
20,859
-1,172
-5% -$18.6K ﹤0.01% 1713
2018
Q4 		$440K Hold
22,031
– – 0.01% 1271
2018
Q3 		$626K Hold
22,031
– – 0.01% 1212
2018
Q2 		$464K Buy
22,031
+2,459
+13% +$46.5K 0.01% 1368
2018
Q1 		$279K Buy
19,572
+1,094
+6% +$15.7K ﹤0.01% 1668
2017
Q4 		$227K Sell
18,478
-17,414
-49% -$245K ﹤0.01% 1838
2017
Q3 		$639K Buy
35,892
+9,338
+35% +$192K ﹤0.01% 1521
2017
Q2 		$673K Buy
26,554
+16,186
+156% +$389K ﹤0.01% 1479
2017
Q1 		$231K Hold
10,368
– – ﹤0.01% 2173
2016
Q4 		$153K Hold
10,368
– – ﹤0.01% 2488
2016
Q3 		$255K Hold
10,368
– – ﹤0.01% 2174
2016
Q2 		$199K Buy
+10,368
New +$142K ﹤0.01% 2325

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EVH Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 6,022 shares — an estimated $197K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EVH in Q2 2016 and held it in 32 quarters. The position peaked at $694K in Q3 2021. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,022 Evolent Health shares in Q2 2024, an estimated $197K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Evolent Health in Q2 2016 and held it in 32 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Evolent Health position peaked at $694K in Q3 2021.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.